BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Büll C, Nason R, Sun L, Van Coillie J, Madriz Sørensen D, Moons SJ, Yang Z, Arbitman S, Fernandes SM, Furukawa S, McBride R, Nycholat CM, Adema GJ, Paulson JC, Schnaar RL, Boltje TJ, Clausen H, Narimatsu Y. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc Natl Acad Sci U S A 2021;118:e2026102118. [PMID: 33893239 DOI: 10.1073/pnas.2026102118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Balneger N, Cornelissen LAM, Wassink M, Moons SJ, Boltje TJ, Bar-Ephraim YE, Das KK, Søndergaard JN, Büll C, Adema GJ. Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions. Cell Mol Life Sci 2022;79:98. [PMID: 35089436 DOI: 10.1007/s00018-021-04027-x] [Reference Citation Analysis]
2 Tseng HC, Hsiao CT, Yamakawa N, Guérardel Y, Khoo KH. Discovery Sulfoglycomics and Identification of the Characteristic Fragment Ions for High-Sensitivity Precise Mapping of Adult Zebrafish Brain-Specific Glycotopes. Front Mol Biosci 2021;8:771447. [PMID: 34988116 DOI: 10.3389/fmolb.2021.771447] [Reference Citation Analysis]
3 Bhattacherjee A, Daskhan GC, Bains A, Watson AES, Eskandari-Sedighi G, St Laurent CD, Voronova A, Macauley MS. Increasing phagocytosis of microglia by targeting CD33 with liposomes displaying glycan ligands. J Control Release 2021;338:680-93. [PMID: 34517042 DOI: 10.1016/j.jconrel.2021.09.010] [Reference Citation Analysis]
4 Visser EA, Moons SJ, Timmermans SBPE, de Jong H, Boltje TJ, Büll C. Sialic acid O-acetylation: From biosynthesis to roles in health and disease. J Biol Chem 2021;297:100906. [PMID: 34157283 DOI: 10.1016/j.jbc.2021.100906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kobiela A, Frackowiak JE, Biernacka A, Hovhannisyan L, Bogucka AE, Panek K, Paul AA, Lukomska J, Wang X, Giannoulatou E, Krolicka A, Zielinski J, Deptula M, Pikula M, Gabrielsson S, Ogg GS, Gutowska-owsiak D. Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors. Front Immunol 2022;13:884530. [DOI: 10.3389/fimmu.2022.884530] [Reference Citation Analysis]
6 Jiang HS, Zhuang SC, Lam CH, Chang LY, Angata T. Recent Progress in the Methodologies to Identify Physiological Ligands of Siglecs. Front Immunol 2021;12:813082. [PMID: 34956244 DOI: 10.3389/fimmu.2021.813082] [Reference Citation Analysis]
7 Stewart N, Wisnovsky S. Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation. Front Mol Biosci 2022;9:934584. [DOI: 10.3389/fmolb.2022.934584] [Reference Citation Analysis]
8 van Houtum EJH, Büll C, Cornelissen LAM, Adema GJ. Siglec Signaling in the Tumor Microenvironment. Front Immunol 2021;12:790317. [PMID: 34966391 DOI: 10.3389/fimmu.2021.790317] [Reference Citation Analysis]
9 Anwar MT, Kawade SK, Huo Y, Adak AK, Sridharan D, Kuo Y, Fan C, Wu H, Lee Y, Angata T, Lin C. Sugar nucleotide regeneration system for the synthesis of Bi- and triantennary N-glycans and exploring their activities against siglecs. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114146] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nason R, Büll C, Konstantinidi A, Sun L, Ye Z, Halim A, Du W, Sørensen DM, Durbesson F, Furukawa S, Mandel U, Joshi HJ, Dworkin LA, Hansen L, David L, Iverson TM, Bensing BA, Sullam PM, Varki A, Vries E, de Haan CAM, Vincentelli R, Henrissat B, Vakhrushev SY, Clausen H, Narimatsu Y. Display of the human mucinome with defined O-glycans by gene engineered cells. Nat Commun 2021;12:4070. [PMID: 34210959 DOI: 10.1038/s41467-021-24366-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Gonzalez-Gil A, Schnaar RL. Siglec Ligands. Cells 2021;10:1260. [PMID: 34065256 DOI: 10.3390/cells10051260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chang LY, Liang SY, Lu SC, Tseng HC, Tsai HY, Tang CJ, Sugata M, Chen YJ, Chen YJ, Wu SJ, Lin KI, Khoo KH, Angata T. Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells. Front Immunol 2022;13:840388. [PMID: 35711441 DOI: 10.3389/fimmu.2022.840388] [Reference Citation Analysis]
13 McKitrick TR, Ackerman ME, Anthony RM, Bennett CS, Demetriou M, Hudalla GA, Ribbeck K, Ruhl S, Woo CM, Yang L, Zost SJ, Schnaar RL, Doering TL. The Crossroads of Glycoscience, Infection, and Immunology. Front Microbiol 2021;12:731008. [PMID: 34646251 DOI: 10.3389/fmicb.2021.731008] [Reference Citation Analysis]
14 Bojar D, Meche L, Meng G, Eng W, Smith DF, Cummings RD, Mahal LK. A Useful Guide to Lectin Binding: Machine-Learning Directed Annotation of 57 Unique Lectin Specificities. ACS Chem Biol 2022. [PMID: 35084820 DOI: 10.1021/acschembio.1c00689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
15 Sun L, Konstantinidi A, Ye Z, Nason R, Zhang Y, Büll C, Kahl-Knutson B, Hansen L, Leffler H, Vakhrushev SY, Yang Z, Clausen H, Narimatsu Y. Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins. J Biol Chem 2021;:101382. [PMID: 34954141 DOI: 10.1016/j.jbc.2021.101382] [Reference Citation Analysis]
16 Konstantinidi A, Nason R, Čaval T, Sun L, Sørensen DM, Furukawa S, Ye Z, Vincentelli R, Narimatsu Y, Vakhrushev SY, Clausen H. Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells. J Biol Chem 2022;:101784. [PMID: 35247390 DOI: 10.1016/j.jbc.2022.101784] [Reference Citation Analysis]
17 Takeda-uchimura Y, Nishitsuji K, Ikezaki M, Akama TO, Ihara Y, Allain F, Uchimura K. Beta3Gn-T7 Is a Keratan Sulfate β1,3 N-Acetylglucosaminyltransferase in the Adult Brain. Front Neuroanat 2022;16:813841. [DOI: 10.3389/fnana.2022.813841] [Reference Citation Analysis]
18 Jung J, Enterina JR, Bui DT, Mozaneh F, Lin PH, Nitin, Kuo CW, Rodrigues E, Bhattacherjee A, Raeisimakiani P, Daskhan GC, St Laurent CD, Khoo KH, Mahal LK, Zandberg WF, Huang X, Klassen JS, Macauley MS. Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands. ACS Chem Biol 2021;16:2673-89. [PMID: 34661385 DOI: 10.1021/acschembio.1c00501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lünemann JD, von Gunten S, Neumann H. Targeting sialylation to treat central nervous system diseases. Trends Pharmacol Sci 2021;42:998-1008. [PMID: 34607695 DOI: 10.1016/j.tips.2021.09.002] [Reference Citation Analysis]
20 Gonzalez-Gil A, Porell RN, Fernandes SM, Maenpaa E, August Li T, Li T, Wong PC, Aoki K, Tiemeyer M, Yu ZJ, Orsburn BC, Bumpus NN, Matthews RT, Schnaar RL. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease. J Biol Chem 2022;:101960. [PMID: 35452678 DOI: 10.1016/j.jbc.2022.101960] [Reference Citation Analysis]